Generics
Increasing access for patients
Our generic medicines, which include complex and branded generics, work in the same way and provide the same clinical benefits as their as their brand-name counterparts and may cost less, providing patients and the healthcare system important savings and medicine options which we believe are essential to making healthcare accessible.
Patients can take generic medications with confidence, knowing that they are identical to existing approved brand-name drugs in the following key aspects:
Quality manufacturing standards
Generic drugmakers are held to the same standards of good manufacturing practices (GMP) by health authorities as brand drugmakers. National health authorities inspect our facilities around the world to ensure that generic manufacturing, packaging and testing sites pass the same quality standards as those of brand-name drugs.
Complex generics
A complex generic is a generic that could have a complex active ingredient, complex formulation, complex route of delivery or complex drug device combinations. At Viatris, we are proud to offer a number of these important medicines to patients, including our Wixela™ Inhub™, the first generic of ADVAIR DISKUS® and glatiramer acetate injection, a generic version of Copaxone®, for example. And we continue to invest in bringing more to market, as more than two-thirds of the products we will launch in the coming years will be either complex generics or biosimilars.
Branded generics
In addition to generics and brand-name products, we also produce branded generics, which are generic drugs that have been given a different brand name than the reference product. We market these drugs in many countries after approval by the appropriate health authorities.
*Not all of the products listed have been approved for use in all countries. To learn which products have been approved for use in a particular country, please visit that country’s page for a full listing of available drug products.
